Search

everythinglearnresearchcommunity

for

Search:↓

Constant light exposure during pregnancy changes newborn rabbits' skin, affecting hair follicles, skin thickness, and pigment cells.

Low-level laser therapy is the most supported treatment for hair loss, but other methods show promise.

PRP treatment improves hair density and thickness for alopecia, but needs more research.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Stopping S100A3 activity slows down hair growth in mice.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

High doses of fluconazole can cause reversible hair loss.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Improper diet, lifestyle, and stress are major causes of hair fall.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

The combined treatment increased hair density in most patients with Androgenetic Alopecia.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Oral minoxidil helps with hair growth but needs more research to fully understand its effectiveness and safety.

Microneedling with PRP and minoxidil (5%) improves hair growth more than minoxidil (5%) alone.

A lotion with Centella asiatica extract reduced hair loss by 41% and increased hair strength without side effects.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Some patients fail bladder function tests due to lower flow rates and higher remaining urine volumes, but the exact reasons for failure are unclear.

Finasteride increases hair weight and count in men with hair loss.

Finasteride does not prevent bladder cancer.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Women with irregular periods have a higher risk of heart disease.